awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33421964-E406544E-DC06-481F-9697-ECC2E062D729
Q33421964-E406544E-DC06-481F-9697-ECC2E062D729
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33421964-E406544E-DC06-481F-9697-ECC2E062D729
Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis.
P2860
Q33421964-E406544E-DC06-481F-9697-ECC2E062D729
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33421964-E406544E-DC06-481F-9697-ECC2E062D729
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cecbf538f55f56173308e578c9b73e813d612de3
P2860
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.